Key facts
- Notable investors include MIG AG, Prettybrook Partners, SHS Capital.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for CoreMedic
- ·The full record, as it builds
Funding rounds
No funding rounds for CoreMedic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CoreMedic
Developer of a transcatheter device designed to improve the treatment for patients with mitral heart valve regurgitation. The company's device is used to replace the ruptured or elongated chordae of the valve and re-establishes the connection of the leaflet of the valve with the papillary muscle to restore the proper function, enabling patients with a minimally invasive alternative to traditional open-heart surgery.
- Sector
- Healthcare
- HQ
- Radolfzell, Germany
- Founded
- 2012
- Employees
- 8
- Website
- coremedic.de/
- Ownership
- Privately Held (backing)
CoreMedic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoreMedic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoreMedic in its N-PORT filings yet. We sweep new filings monthly.